<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Bismuth Subsalicylate - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../sickbay-shared.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Bismuth Subsalicylate</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">GI</div>
      <h1>Bismuth Subsalicylate</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Bismuth Subsalicylate 300-325mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Diarrhea (acute, non-bloody)</strong>
            <ul>
              <li>525 mg (2 tablets if using 262 mg tablets; or use as labeled) PO every 30–60 minutes as needed</li>
              <li>Maximum 8 doses per 24 hours</li>
              <li>Do not use for more than 2 days without medical reassessment</li>
            </ul>
          </li>
          <li><strong>Nausea / indigestion / heartburn</strong>
            <ul>
              <li>262–525 mg PO as needed</li>
              <li>Maximum 8 doses per 24 hours</li>
            </ul>
          </li>
          <li><strong>Traveler's diarrhea prophylaxis (when recommended)</strong>
            <ul>
              <li>262–525 mg PO four times daily with meals and at bedtime (follow local/travel medicine guidance)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Symptomatic relief of mild diarrhea, nausea, heartburn, indigestion, and upset stomach</li>
          <li>Traveler's diarrhea (treatment and prophylaxis when indicated)</li>
          <li>Adjunct in H. pylori eradication regimens (quadruple therapy; provider-directed)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Salicylate hypersensitivity (including aspirin allergy)</li>
          <li>Active bleeding disorder or concurrent anticoagulant use (contains salicylate)</li>
          <li>Renal impairment (risk of bismuth accumulation)</li>
          <li>Gout (may affect uric acid levels)</li>
          <li>Avoid in children/adolescents with viral illness (Reye's syndrome risk from salicylate component)</li>
          <li>Pregnancy/lactation: limited safety data; generally avoid or use only if clearly needed</li>
          <li>Caution with concurrent aspirin or NSAIDs (additive salicylate effects)</li>
          <li>Do not use for high fever or bloody/severe diarrhea (may mask serious conditions)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Darkening of tongue and/or stools (temporary, benign; counsel patient)</li>
          <li>Constipation (with prolonged or high-dose use)</li>
          <li>Nausea, vomiting (uncommon)</li>
          <li>Salicylate toxicity (rare; more likely with overdose or renal impairment): tinnitus, hearing loss, confusion</li>
          <li>Neurotoxicity (very rare; bismuth encephalopathy with chronic high-dose use)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Chew tablets well or dissolve in mouth before swallowing, or swallow whole with water</li>
          <li>May be taken with or without food</li>
          <li>Shake liquid suspension well before use (if liquid formulation available)</li>
          <li>Counsel patient about harmless darkening of tongue/stools</li>
          <li>Advise to maintain hydration, especially with diarrhea</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom relief (diarrhea frequency, nausea, indigestion)</li>
          <li>Hydration status (especially with ongoing diarrhea)</li>
          <li>Duration of symptoms: reassess if diarrhea persists beyond 2 days or worsens (may indicate bacterial/parasitic infection or other serious condition)</li>
          <li>Signs of salicylate toxicity if prolonged use or high doses: tinnitus, hearing changes, confusion</li>
          <li>Stool appearance: stop and seek care if bloody diarrhea or high fever develops</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>First-line for mild acute diarrhea; reassess early if no improvement or if symptoms suggest bacterial/severe infection (fever, blood, severe cramping)</li>
          <li>Ensure adequate oral rehydration alongside bismuth use</li>
          <li>Document start date, dose, frequency, and response clearly</li>
          <li>If used for traveler's diarrhea: consider antibiotic therapy per protocol if moderate-severe or not improving within 24–48 hours</li>
          <li>Warn crew about stool/tongue darkening to avoid alarm</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (Pepto-Bismol): <a href="https://pdf.hres.ca/dpd_pm/00074050.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00074050.PDF</a></li>
          <li>CDC Yellow Book – Travelers' Diarrhea: <a href="https://wwwnc.cdc.gov/travel/yellowbook/2024/preparing/travelers-diarrhea" target="_blank" rel="noopener">https://wwwnc.cdc.gov/travel/yellowbook/2024/preparing/travelers-diarrhea</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
